These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29286453)

  • 1. Alternative In Vitro Methods for the Determination of Viral Capsid Structural Integrity.
    Moore MD; Mertens BS; Jaykus LA
    J Vis Exp; 2017 Nov; (129):. PubMed ID: 29286453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Norovirus Aptamer Exhibits High Degree of Target Conformation-Dependent Binding Similar to That of Receptors and Discriminates Particle Functionality.
    Moore MD; Bobay BG; Mertens B; Jaykus LA
    mSphere; 2016; 1(6):. PubMed ID: 27830193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of a DNA aptamer against norovirus capsid protein VP1.
    Beier R; Pahlke C; Quenzel P; Henseleit A; Boschke E; Cuniberti G; Labudde D
    FEMS Microbiol Lett; 2014 Feb; 351(2):162-9. PubMed ID: 24372686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics in the murine norovirus capsid revealed by high-resolution cryo-EM.
    Snowden JS; Hurdiss DL; Adeyemi OO; Ranson NA; Herod MR; Stonehouse NJ
    PLoS Biol; 2020 Mar; 18(3):e3000649. PubMed ID: 32231352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterologous expression of human norovirus GII.4 VP1 leads to assembly of T=4 virus-like particles.
    Devant JM; Hofhaus G; Bhella D; Hansman GS
    Antiviral Res; 2019 Aug; 168():175-182. PubMed ID: 31145925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanobodies targeting norovirus capsid reveal functional epitopes and potential mechanisms of neutralization.
    Koromyslova AD; Hansman GS
    PLoS Pathog; 2017 Nov; 13(11):e1006636. PubMed ID: 29095961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for broad detection of genogroup II noroviruses by a monoclonal antibody that binds to a site occluded in the viral particle.
    Hansman GS; Taylor DW; McLellan JS; Smith TJ; Georgiev I; Tame JR; Park SY; Yamazaki M; Gondaira F; Miki M; Katayama K; Murata K; Kwong PD
    J Virol; 2012 Apr; 86(7):3635-46. PubMed ID: 22278249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target Affinity and Structural Analysis for a Selection of Norovirus Aptamers.
    Schilling-Loeffler K; Rodriguez R; Williams-Woods J
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of norovirus particles with citrate.
    Koromyslova AD; White PA; Hansman GS
    Virology; 2015 Nov; 485():199-204. PubMed ID: 26295280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the Applicability of Capsid-Integrity Assays for Detecting Infectious Norovirus Inactivated by Heat or UV Irradiation.
    Walker DI; Cross LJ; Stapleton TA; Jenkins CL; Lees DN; Lowther JA
    Food Environ Virol; 2019 Sep; 11(3):229-237. PubMed ID: 31165999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for murine norovirus engagement of bile acids and the CD300lf receptor.
    Nelson CA; Wilen CB; Dai YN; Orchard RC; Kim AS; Stegeman RA; Hsieh LL; Smith TJ; Virgin HW; Fremont DH
    Proc Natl Acad Sci U S A; 2018 Sep; 115(39):E9201-E9210. PubMed ID: 30194229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual self-assembly properties of Norovirus Newbury2 virus-like particles.
    Tresset G; Decouche V; Bryche JF; Charpilienne A; Le Cœur C; Barbier C; Squires G; Zeghal M; Poncet D; Bressanelli S
    Arch Biochem Biophys; 2013 Sep; 537(1):144-52. PubMed ID: 23871846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of oxidative damages on viral capsid protein for evaluating structural integrity and infectivity of human norovirus.
    Sano D; Pintó RM; Omura T; Bosch A
    Environ Sci Technol; 2010 Jan; 44(2):808-12. PubMed ID: 20000802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanobody-Mediated Neutralization Reveals an Achilles Heel for Norovirus.
    Koromyslova AD; Devant JM; Kilic T; Sabin CD; Malak V; Hansman GS
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flexibility in surface-exposed loops in a virus capsid mediates escape from antibody neutralization.
    Kolawole AO; Li M; Xia C; Fischer AE; Giacobbi NS; Rippinger CM; Proescher JB; Wu SK; Bessling SL; Gamez M; Yu C; Zhang R; Mehoke TS; Pipas JM; Wolfe JT; Lin JS; Feldman AB; Smith TJ; Wobus CE
    J Virol; 2014 Apr; 88(8):4543-57. PubMed ID: 24501415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric VLPs with GII.3 P2 domain in a backbone of GII.4 VP1 confers novel HBGA binding ability.
    Huo Y; Wang W; Ling T; Wan X; Ding L; Shen S; Huo J; Zhang S; Wang M; Wang Y; Liu Y
    Virus Res; 2016 Sep; 224():1-5. PubMed ID: 27521750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of nucleic acid aptamers targeting the capsid P domain of a human norovirus GII.4 strain.
    Moore MD; Escudero-Abarca BI; Suh SH; Jaykus LA
    J Biotechnol; 2015 Sep; 209():41-9. PubMed ID: 26080079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope mapping of histo blood group antigens bound to norovirus VLPs using STD NMR experiments reveals fine details of molecular recognition.
    Fiege B; Leuthold M; Parra F; Dalton KP; Meloncelli PJ; Lowary TL; Peters T
    Glycoconj J; 2017 Oct; 34(5):679-689. PubMed ID: 28823097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural heterogeneity of a human norovirus vaccine candidate.
    Devant JM; Hansman GS
    Virology; 2021 Jan; 553():23-34. PubMed ID: 33202318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of methods for purification and concentration of norovirus GII-4 capsid virus-like particles.
    Huhti L; Blazevic V; Nurminen K; Koho T; Hytönen VP; Vesikari T
    Arch Virol; 2010 Nov; 155(11):1855-8. PubMed ID: 20721592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.